- Ogivri® was listed on the PBS on 1 August 2019.
- Herzuma® was listed on the PBS on 1 November 2019.
- Kanjinti® was listed on the PBS on 1 December 2019.
- Ontruzant® was listed on the PBS on 1 January 2020.
- Trazimera® was listed on the PBS on 1 May 2020.
These brands are listed under the Efficient Funding of Chemotherapy arrangements of the Section 100 Highly Specialised Drugs Program.
Biosimilar medicine fact sheet – trastuzumab
About this resource
Publication date:
Publication type:
Fact sheet
Audience:
General public
Language:
English
Part of a collection: